Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $120,648 | 27 | 80.7% |
| Food and Beverage | $11,036 | 199 | 7.4% |
| Travel and Lodging | $10,680 | 25 | 7.1% |
| Consulting Fee | $7,042 | 3 | 4.7% |
| Honoraria | $136.88 | 3 | 0.1% |
| Gift | $19.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $142,029 | 156 | $0 (2024) |
| Astellas Pharma US Inc | $2,644 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,185 | 30 | $0 (2024) |
| Alcon Vision LLC | $571.82 | 5 | $0 (2024) |
| Alcon Laboratories Inc | $494.93 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $337.41 | 6 | $0 (2021) |
| Allergan, Inc. | $310.59 | 9 | $0 (2021) |
| TissueTech, Inc. | $262.36 | 2 | $0 (2017) |
| CooperVision Inc. | $211.95 | 2 | $0 (2024) |
| Biogen, Inc. | $190.97 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,838 | 48 | Genentech USA, Inc. ($24,292) |
| 2023 | $24,492 | 30 | Genentech USA, Inc. ($23,990) |
| 2022 | $30,582 | 35 | Genentech USA, Inc. ($29,965) |
| 2021 | $5,821 | 17 | Genentech USA, Inc. ($5,471) |
| 2020 | $6,774 | 16 | Genentech USA, Inc. ($6,634) |
| 2019 | $25,330 | 37 | Genentech USA, Inc. ($24,757) |
| 2018 | $26,849 | 38 | Genentech USA, Inc. ($26,374) |
| 2017 | $1,876 | 37 | Genentech USA, Inc. ($544.90) |
All Payment Transactions
258 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: EYE CARE | ||||||
| 12/09/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,640.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/02/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $28.35 | General |
| Category: Ophthalmology | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.42 | General |
| Category: Ophthalmology | ||||||
| 11/04/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Ophthalmology | ||||||
| 10/22/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Ophthalmology | ||||||
| 10/11/2024 | Alcon Vision LLC | LenSx (Device) | Food and Beverage | In-kind items and services | $114.10 | General |
| Category: Ophthalmology | ||||||
| 10/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $31.18 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/01/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $38.32 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/16/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | In-kind items and services | $1,605.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/16/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $82.38 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/30/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Ophthalmology | ||||||
| 08/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Travel and Lodging | In-kind items and services | $40.00 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.98 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: EYE CARE | ||||||
| 05/29/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 3,897 | 19,112 | $7.7M | $3.0M |
| 2022 | 14 | 3,383 | 12,504 | $6.4M | $2.6M |
| 2021 | 14 | 3,112 | 11,032 | $5.4M | $2.4M |
| 2020 | 16 | 2,554 | 9,398 | $4.8M | $2.2M |
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 199 | 2,178 | $2.7M | $1.5M | 55.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 77 | 2,138 | $1.1M | $382,201 | 35.8% |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 2023 | 43 | 1,400 | $616,000 | $241,299 | 39.2% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 21 | 5,760 | $244,800 | $167,248 | 68.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 360 | 1,756 | $1.2M | $161,818 | 13.6% |
| J3590 | Unclassified biologics | Office | 2023 | 35 | 52 | $648,000 | $152,621 | 23.6% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 38 | 521 | $260,500 | $112,431 | 43.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 945 | 1,474 | $257,950 | $87,881 | 34.1% |
| 92250 | Photography of the retina | Office | 2023 | 1,127 | 1,728 | $259,200 | $43,518 | 16.8% |
| 92134 | Imaging of retina | Office | 2023 | 420 | 1,416 | $141,600 | $40,548 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 197 | 197 | $62,055 | $22,019 | 35.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 148 | 153 | $38,250 | $14,963 | 39.1% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 11 | 12 | $60,000 | $10,451 | 17.4% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 11 | 11 | $55,000 | $9,215 | 16.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 110 | 110 | $23,650 | $8,611 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 65 | $16,250 | $5,666 | 34.9% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 54 | 102 | $10,200 | $5,461 | 53.5% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 18 | 18 | $27,000 | $3,102 | 11.5% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 19 | 21 | $4,515 | $698.48 | 15.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 172 | 1,898 | $2.4M | $1.4M | 57.3% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 116 | 4,055 | $2.0M | $894,907 | 44.1% |
| 67028 | Injection of drug into eye | Office | 2022 | 316 | 1,617 | $1.1M | $145,372 | 13.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 797 | 1,340 | $225,620 | $79,712 | 35.3% |
| 92134 | Imaging of retina | Office | 2022 | 423 | 1,422 | $142,200 | $41,574 | 29.2% |
| 92250 | Photography of the retina | Office | 2022 | 959 | 1,488 | $223,200 | $36,916 | 16.5% |
About Dr. Daniel Bennett, MD
Dr. Daniel Bennett, MD is a Ophthalmology healthcare provider based in Raleigh, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1376715565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Bennett, MD has received a total of $149,562 in payments from pharmaceutical and medical device companies, with $27,838 received in 2024. These payments were reported across 258 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($120,648).
As a Medicare-enrolled provider, Bennett has provided services to 12,946 Medicare beneficiaries, totaling 52,046 services with total Medicare billing of $10.2M. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Student in an Organized Health Care Education/Training Program
- Location Raleigh, NC
- Active Since 03/27/2008
- Last Updated 09/24/2020
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376715565
Products in Payments
- Lucentis (Biological) $64,642
- Vabysmo (Drug) $48,282
- VABYSMO (Drug) $29,137
- Izervay (Drug) $2,575
- EYLEA (Biological) $677.55
- EYLEA HD (Biological) $407.78
- OZURDEX (Drug) $393.33
- Prokera (Device) $262.36
- ACTIVEFOCUS (Device) $241.20
- EYLEA AFLIBERCEPT INJECTION (Biological) $239.30
- Syfovre (Drug) $159.82
- ForeseeHome (Device) $156.43
- YUTIQ (Drug) $145.00
- iStent inject W (Device) $136.92
- Cimerli (Biological) $133.64
- AcrySof IQ VIVITY IOL (Device) $129.71
- ARGOS (Device) $128.08
- CyPass (Device) $121.84
- LenSx (Device) $114.10
- Clareon (Device) $114.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Raleigh
Preeya Gupta, Md, MD
Ophthalmology — Payments: $1.7M
Raynor Casey, M.d, M.D
Ophthalmology — Payments: $35,026
Sachin Mudvari, Md, MD
Ophthalmology — Payments: $33,257
John Thordsen, Md, MD
Ophthalmology — Payments: $31,927
Isaac Porter, M.d, M.D
Ophthalmology — Payments: $9,542
Dr. Nitin Gupta, M.d., M.p.h, M.D., M.P.H
Ophthalmology — Payments: $8,730